CXCR4 and B-cell chronic lymphocytic leukemia: Furthermore, the CXCR4 bis(cyclam) ligand BAT1 has been used for the targeted delivery of doxorubicin to CXCR4+ chronic lymphocytic leukemia model, exhibiting a similar dual action mechanism [213].